• BUZUD Continuous Glucose Monitoring System 2.0
  • BUZUD Continuous Glucose Monitoring System 2.0
  • BUZUD Continuous Glucose Monitoring System 2.0
1 3

Buzud

BUZUD Continuous Glucose Monitoring System 2.0

BUZUD Continuous Glucose Monitoring System 2.0

$103.53 SGD
$103.53 SGD
促销 售罄
结账时计算的运费。
Clinical Summary: The BUZUD Continuous Glucose Monitoring System (CGMS) 2.0 is a Class II medical device that provides real-time interstitial glucose monitoring via a subcutaneously inserted sensor, transmitting readings every 60 seconds via Bluetooth to a companion mobile application. The system delivers 1,440 glucose data points per day over a 15-day sensor lifespan, enabling comprehensive glycaemic trend analysis. Indicated for continuous glucose monitoring in individuals aged 2 years and older with diabetes mellitus, and approved by the Singapore Health Sciences Authority (HSA).

Product Overview

The BUZUD CGMS 2.0 represents an advancement in ambulatory glucose monitoring technology, designed for patients with Type 1 or Type 2 diabetes mellitus who require continuous insight into interstitial glucose levels. The sensor, approximately the diameter of a 50-cent coin, is applied subcutaneously and measures glucose concentrations in the interstitial fluid every 60 seconds, transmitting data wirelessly via Bluetooth Low Energy (BLE) to the BUZUD mobile application on iOS or Android devices.

Unlike traditional fingerstick glucometers that provide isolated point-in-time readings, the BUZUD CGMS 2.0 generates 1,440 readings per 24-hour period, enabling clinicians and patients to identify glycaemic patterns including nocturnal hypoglycaemia, postprandial glucose excursions, and dawn phenomenon. The system includes configurable high and low glucose alerts, AI-powered nutrition analysis within the companion app, and exportable glucose reports in Ambulatory Glucose Profile (AGP) format for clinical review. The device is manufactured by Fosun Trade Medical Device and holds HSA approval for distribution in Singapore.

Specifications

Manufacturer Fosun Trade Medical Device (distributed by BUZUD Singapore)
Device Classification Class II Medical Device
Measurement Method Electrochemical enzyme-based interstitial glucose sensing
Sensor Lifespan 15 days per sensor
Reading Frequency Every 60 seconds (1,440 readings per day)
Connectivity Bluetooth Low Energy (BLE) — automatic sync, no manual scanning required
Measurement Range 2.2–27.8 mmol/L (40–500 mg/dL)
Sensor Dimensions Approximately 50-cent coin diameter; slim profile for discreet wear
Age Indication 2 years and older
Companion App BUZUD Mobile App (iOS and Android) with AI nutrition analysis
Alert Functions Configurable high glucose, low glucose, and rapid change alerts
Water Resistance IP27 — suitable for showering; not for swimming or submersion
Regulatory Approval HSA Singapore approved; CE marked (EU MDR 2017/745 compliant)
Quality Standards Manufactured under ISO 13485 quality management system
Packaging 1 transmitter + 2 sensors per starter kit

Clinical Indications

  • Type 1 diabetes mellitus — continuous glucose trend monitoring for insulin dose adjustment and hypoglycaemia prevention
  • Type 2 diabetes mellitus on insulin therapy — identification of glycaemic patterns to optimise basal-bolus regimens
  • Gestational diabetes mellitus — real-time glucose monitoring during pregnancy for tighter glycaemic control per NICE NG3 guidelines
  • Pre-diabetes and metabolic syndrome — glucose trend awareness for lifestyle intervention and dietary modification
  • Nocturnal hypoglycaemia detection — configurable low glucose alerts during sleep for insulin-dependent patients
  • Postprandial glucose excursion analysis — identification of food-specific glycaemic responses for dietary counselling

Frequently Asked Questions

How accurate is the BUZUD CGMS 2.0 compared to fingerstick glucose meters?

The BUZUD CGMS 2.0 measures interstitial glucose, which has a physiological lag of approximately 5 to 15 minutes compared to capillary blood glucose. During periods of rapidly changing glucose levels, sensor readings may diverge from fingerstick values. The system meets ISO 15197:2013 accuracy requirements for glucose monitoring devices. Calibration via fingerstick is recommended during the initial warm-up period and when sensor readings do not match symptoms.

Is the BUZUD CGMS 2.0 approved for use in Singapore?

Yes. The BUZUD CGMS 2.0 is approved by the Singapore Health Sciences Authority (HSA) as a Class II medical device. It also holds CE marking under the European Medical Device Regulation (EU MDR 2017/745) and is manufactured under ISO 13485 quality management standards.

Can the sensor be worn during showering or exercise?

The sensor carries an IP27 water resistance rating, which permits exposure to brief water contact such as showering. It is not rated for swimming, bathing, or prolonged submersion. During vigorous exercise, an over-patch adhesive is recommended to secure the sensor and prevent dislodgement.

How does the AI nutrition analysis feature work?

The BUZUD companion app includes an AI-powered nutrition analysis module that correlates food intake logs with glucose response data. By photographing meals or manually logging food items, users can identify which foods cause significant postprandial glucose excursions, supporting evidence-based dietary modifications in consultation with a dietitian or diabetes educator.

Where can I purchase BUZUD CGMS 2.0 sensors and transmitters in Singapore?

The BUZUD CGMS 2.0 starter kit and replacement sensors are available through EMIS+ at emis.asia, an authorised distributor in Singapore. The device is also stocked at selected hospital pharmacies including TTSH Pharmezy. No prescription is required for purchase in Singapore, though consultation with a healthcare professional is recommended for initial setup and interpretation of glucose data.

查看完整详细信息